The ROADSTER Study
Prospective, single arm, multi-center trial of the TCAR Procedure using the ENROUTE® Transcarotid NeuroprotectionSystem (NPS) in high surgical risk patients with carotid artery stenosis.
“The overall stroke rate of 1.4% is the lowest reported to date for any propsective multi-center trial of carotid stenting.”
– J Vasc Surg 2015;62:1227-35
Results of the ROADSTER study
![chart](https://silkroadmed.com/wp-content/uploads/2020/10/chart.jpg)
![chart2](https://silkroadmed.com/wp-content/uploads/2020/10/chart2.jpg)
Cranial Nerve Injury Rates
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ROADSTER_Stats_1.png)
Transcarotid Efficiency
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ROADSTER_Stats_2.png)
Procedure Time
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ROADSTER_Stats_3-1.png)
Local Anesthesia Use
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ROADSTER_Stats_LocalAnesthesiaUse-1.png)
Related publications
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
Results of the ROADSTER Multicenter Trial of Transcarotid Stenting with Dynamic Flow Reversal.
Kwolek CJ et al.
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
One-Year Results of the ROADSTER Multicenter Trial of Transcarotid Stenting with Dynamic Flow Reversal
Mahmoud Malas et al.
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
Pre- and Post-TCAR Characteristics of Common Carotid Artery: A Post Hoc Analysis of ROADSTER-1
Raghu L. Motaganahalli et al.
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
The ROADSTER Investigational Device Exemption Trial Leads to FDA Approval of the First Stent Labeled for TCAR
Manish Mehta et al.
Discover more clinical studies
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResult_LandingPage_TCAR_PROOF.jpg)
First in man results using ENROUTE® Transcarotid Neuroprotection System.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-2-ROADSTER-2-Study.jpg)
Post Approval registry validating safety and efficacy of the ENROUTE Stent.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-3-TCAR-Surveillance-Study.jpg)
Real world population data validating CEA-like outcomes.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-4-TCAR-vs-TF-CAS.jpg)
Validation of superior outcomes
to TF-CAS.